Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics

Regulatory enforcement stories

Nov 6, 2026

New CMS rule ties Medicare billing privileges to owner conduct

CMS finalized a rule targeting Medicare providers owned by companies with violations in other programs, requiring reenrollment for home health and other providers based on owners' misconduct records.

Nov 6, 2026·2 sources
00
Nov 3, 2026

Philips reaches preliminary DOJ settlement over sleep and respiratory device recall

Dutch medical device manufacturer Philips has reached a preliminary agreement with the US Department of Justice to resolve investigations linked to its 2021 global recall of sleep and respiratory-care devices. The company booked a €288 million provision in Q3 related to the settlement.

Nov 3, 2026·3 sources
00
Oct 30, 2026

Patients use AI-edited photos to access weight-loss drugs, pharmacies warn

Pharmacies are warning that patients are increasingly using AI-edited photographs to make themselves appear heavier in order to fraudulently access weight-loss treatments such as Mounjaro and Wegovy. The pharmacies are calling for tougher verification checks to prevent such deceptions.

Oct 30, 2026·1 source
00
Oct 27, 2026

FDA warns Amgen over misleading Vectibix cancer drug promotional video

The US FDA warned Amgen that a promotional video for its colorectal cancer drug Vectibix was misleading because it highlighted benefits while failing to adequately disclose serious safety risks and patient limitations. The warning letter was issued on Tuesday.

Oct 27, 2026·2 sources
00
Oct 17, 2026

Federal Election Commission unable to enforce campaign finance law ahead of midterms

The Federal Election Commission has been unable to perform most of its duties, including advising campaigns or investigating alleged violations of campaign finance law, as the 2026 midterm elections approach. The agency's incapacitation leaves a significant gap in oversight of campaign spending and finance regulations during the election cycle.

Oct 17, 2026·3 sources
00
Oct 14, 2026

Sanofi avoids EU fine after settling antitrust probe over disparaging rival vaccine

The European Commission accepted Sanofi's commitments to end an antitrust investigation into allegations the company disparaged CSL Seqirus' competing flu vaccine. The commitments will become legally binding for Sanofi, allowing it to avoid a fine.

Oct 14, 2026·3 sources
00
Sep 8, 2026

Justice Department widens antitrust probe into Fox's $22 billion Roku acquisition

The U.S. Department of Justice is expanding its antitrust investigation into Fox's $22 billion deal to acquire streaming platform Roku, with DOJ staff planning to seek additional information from the companies involved.

Sep 8, 2026·2 sources
00
Sep 3, 2026

Michigan court blocks Kalshi from operating in state as New Jersey seeks Supreme Court review

A Michigan state court issued a preliminary injunction barring prediction-market platform Kalshi from offering services in the state, with Judge Rosemarie Aquilina threatening a $500,000 daily fine. Separately, New Jersey filed a petition for Supreme Court review seeking clarity on regulatory authority over prediction markets.

Sep 3, 2026·2 sources
00
Jun 26, 2026

European Commission Opens Antitrust Investigation Into Sanofi's Flu Vaccine Marketing Practices

The European Commission launched an antitrust probe into Sanofi for allegedly disparaging a rival's flu vaccine in its marketing campaigns, potentially violating competition rules.

Jun 26, 2026·3 sources
00
May 13, 2026

FDA Reverses Course on Flavored Vapes, Allowing Products Without Authorization to Remain on Market

The FDA has implemented a new policy that will permit some flavored vaping products to stay on the market without agency authorization, raising concerns among public health experts after the agency previously warned about harmful kratom-derived products.

May 13, 2026·2 sources
00

Top claims

  • ▪The Centers for Medicare & Medicaid Services promised to investigate more providers using advanced analytics of enrollment data and fraud indicators
  • ▪The Trump administration cited minimal operational oversight, patient exploitation, and rapid private equity growth as reasons why home health, hospice, and medical equipment providers pose high payment integrity risks
  • ▪Under the 2027 Home Health Prospective Payment System final rule, enforcement actions taken against healthcare providers will apply retroactively to the date CMS or its contractors notify providers of noncompliance

Subtopics

Antitrust & competition2Healthcare fraud2AI antitrust & competition1AI content detection1AI misuse1Cancer & Oncology1Corporate earnings1Crypto regulation1Department of Justice1Drug Approval and Clinical Trials1Drug labeling & regulation1Drug Policy, Pricing & Approval1Drug safety1Eating disorders & disordered eating1Election integrity1European Union1FDA regulation1Federal agencies1Generative AI1GLP-11Healthcare Access and Insurance1Healthcare providers1Media consolidation1Medicare1

Related timelines

Congress

110 stories

Crypto hacks

100 stories

Iran War

209 stories

Payments

118 stories

Russia-Ukraine war

136 stories